Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
5
×
Tags
life sciences
national blog main
national top stories
san francisco top stories
5
×
boston blog main
boston top stories
national
new york top stories
san francisco blog main
clinical trials
new york blog main
san diego blog main
san diego top stories
biotech
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
raleigh-durham blog main
raleigh-durham top stories
roche
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
allergan
antidepressant
assurex health
billy dunn
biogen
blueprint medicines
brca-1
brca-2
bristol-myers squibb
What
medicine
5
×
new
5
×
approved
cancer
drug
genetic
fda
known
atrophy
cas
cells
centers
crispr
cut
daily
data
deeper
defect
depression
disease
dna
drive
edited
editing
event
evrysdi
fatty
fears
fingerprint
flag
friday
gene
going
green
guardian
guesswork
guide
helps
home
horizon
Language
unset
Current search:
xconomy.com
×
medicine
×
photo
×
" san francisco top stories "
×
new
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
6 years ago
CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells
@xconomy.com
6 years ago
Will New Study Cut Guesswork for Depression Medicine Prescriptions?